PDE inhibitors currently in early clinical trials for the treatment of asthma
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.921157
Reference69 articles.
1. Phosphodiesterase Inhibitors in the Treatment of Inflammatory Diseases
2. Phosphodiesterase inhibitors in airways disease
3. Phosphodiesterases
4. Selective PDE inhibitors as novel treatments for respiratory diseases
5. Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 14-3-3 interaction with phosphodiesterase 8A sustains PKA signaling and downregulates the MAPK pathway;Journal of Biological Chemistry;2024-03
2. Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules;Frontiers in Pharmacology;2022-11-24
3. Human Pluripotent Stem Cell-Derived Alveolar Organoid with Macrophages;International Journal of Molecular Sciences;2022-08-16
4. Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy;Antimicrobial Agents and Chemotherapy;2022-07-19
5. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach;Cells;2022-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3